Annamycin
From Self-sufficiency
Not to be confused with Ansamycin.
| File:Annamycin.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
(7S,9S)-7-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-3-iodo- 6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9- (2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione | |
| Identifiers | |
| CAS Number | 92689-49-1 |
| ATC code | none |
| PubChem | CID 115212 |
| Chemical data | |
| Formula | C26H25IO11 |
| Molar mass | 640.375 g/mol[[Script error: No such module "String".]] |
Annamycin is an anthracycline antibiotic being investigated for the treatment of cancer.
Further reading
- Priebe W (1995). "Mechanism of action-governed design of anthracycline antibiotics: a "turn-off/turn-on" approach". Current Pharmaceutical Design. 1 (1): 51–68.
- Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
External links
| 40px | This antineoplastic or immunomodulatory drug article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Anthracyclines
- Antineoplastic and immunomodulating drug stubs
- 2Fix
